Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 26.
doi: 10.1111/epi.18524. Online ahead of print.

Stereoelectroencephalography-guided radiofrequency thermocoagulation for drug-resistant epilepsy: A meta-analysis

Pavel S Pichardo-Rojas  1   2 , Diego Pichardo-Rojas  2   3 , Carlos A Zarate-Duran  2   4 , Amir Hjeala-Varas  2   5 , Roberto Sanchez-Velez  2   6 , Aldo Barrón-Lomelí  2   7 , Mario Cesar Torres Chavez  2   8 , Ernesto A Gutierrez Herrera  2   8 , Oswaldo Torres-Madrid  2   9 , Ahmed M Raslan  10 , Ahmed Negida  11   12 , Vanessa Milanese  13
Affiliations
Review

Stereoelectroencephalography-guided radiofrequency thermocoagulation for drug-resistant epilepsy: A meta-analysis

Pavel S Pichardo-Rojas et al. Epilepsia. .

Abstract

Objective: In patients with focal drug-resistant epilepsy (DRE), resective epilepsy surgery correlates with high rates of remission. However, in cases where the epileptic region is deemed surgically inaccessible, or when it involves a complex network, stereoelectroencephalography-guided radiofrequency thermocoagulation (SEEG-RFTC) might be an alternative therapeutic strategy. However, most of the available evidence is limited to small observational studies. An updated meta-analysis is warranted to provide a comprehensive assessment of SEEG-RFTC in patients with DRE.

Methods: Databases were searched until September 9, 2023 to identify published studies reporting on the effectiveness of SEEG-RFTC in patients with DRE. The primary outcomes of interest were the 1-year seizure-freedom rate and response rate (50% seizure frequency decrease from baseline). These outcomes were pooled using the inverse variance and a random-effects model.

Results: We screened 182 articles and included 16 retrospective cohort studies. A total of 437 unique patients from 12 nonoverlapping cohorts were analyzed for seizure and complication outcomes. The pooled seizure-free rate after 1 year was 37.8% (95% confidence interval [CI] = 24.7%-50.8%), whereas the seizure response rate after 1 year was 69.7% (95% CI = 52.7%-86.7%). There was high heterogeneity among the included studies. Subgroup analysis revealed that patients with nodular heterotopia achieved higher rates of seizure freedom (57.1%, 95% CI = 38.8%-75.5%) compared to those with cortical dysplasia (CD) and magnetic resonance imaging-negative conditions. Furthermore, hippocampal sclerosis patients exhibited higher seizure freedom rates (66.7%, 95% CI = 49.8%-83.5%) than those with CD (12.0%, 95% CI = .0%-24.7%).

Significance: SEEG-RFTC might be an effective therapeutic option for seizure control in patients with DRE who undergo SEEG for DRE workup. The role of SEEG-RFTC as a potential adjunct therapy to laser interstitial thermal therapy or surgical resection should be explored. This study highlights the need for well-designed clinical trials to compare SEEG-guided RFTC with other therapeutic modalities.

Keywords: SEEG‐guided; drug‐resistant epilepsy; epilepsy surgery; radiofrequency thermocoagulation; stereotactic.

PubMed Disclaimer

References

REFERENCES

    1. Yoo JY, Panov F. Identification and treatment of drug‐resistant epilepsy. Continuum. 2019;25(2):362–380.
    1. Gonzalez‐Martinez J, Mullin J, Bulacio J, Gupta A, Enatsu R, Najm I, et al. Stereoelectroencephalography in children and adolescents with difficult‐to‐localize refractory focal epilepsy. Neurosurgery. 2014;75(3):258–268; discussion 267–268.
    1. Tandon N, Tong BA, Friedman ER, Johnson JA, von Allmen G, Thomas MS, et al. Analysis of morbidity and outcomes associated with use of subdural grids vs Stereoelectroencephalography in patients with intractable epilepsy. JAMA Neurol. 2019;76(6):672–681.
    1. Cardinale F, Rizzi M, Vignati E, Cossu M, Castana L, d'Orio P, et al. Stereoelectroencephalography: retrospective analysis of 742 procedures in a single centre. Brain. 2019;142(9):2688–2704.
    1. Oluigbo CO, Gaillard WD, Koubeissi MZ. The end justifies the means‐a call for nuance in the increasing Nationwide adoption of Stereoelectroencephalography over subdural electrode monitoring in the surgical evaluation of intractable epilepsy. JAMA Neurol. 2022;79(3):221–222.

LinkOut - more resources